NO166302C - Fremgangsmaate for diagnose av reumatoid artritt eller osteoartritt. - Google Patents

Fremgangsmaate for diagnose av reumatoid artritt eller osteoartritt.

Info

Publication number
NO166302C
NO166302C NO860191A NO860191A NO166302C NO 166302 C NO166302 C NO 166302C NO 860191 A NO860191 A NO 860191A NO 860191 A NO860191 A NO 860191A NO 166302 C NO166302 C NO 166302C
Authority
NO
Norway
Prior art keywords
osteoarthritis
diagnosis
arths
reumatoid
procedure
Prior art date
Application number
NO860191A
Other languages
English (en)
Norwegian (no)
Other versions
NO166302B (no
NO860191L (no
Inventor
Raymond A Dwek
Thomas W Rademacher
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of NO860191L publication Critical patent/NO860191L/no
Publication of NO166302B publication Critical patent/NO166302B/no
Publication of NO166302C publication Critical patent/NO166302C/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/827Lectins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electroluminescent Light Sources (AREA)
  • Control Of El Displays (AREA)
NO860191A 1985-01-22 1986-01-21 Fremgangsmaate for diagnose av reumatoid artritt eller osteoartritt. NO166302C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/693,075 US4659659A (en) 1985-01-22 1985-01-22 Diagnostic method for diseases having an arthritic component

Publications (3)

Publication Number Publication Date
NO860191L NO860191L (no) 1986-07-23
NO166302B NO166302B (no) 1991-03-18
NO166302C true NO166302C (no) 1991-06-26

Family

ID=24783210

Family Applications (1)

Application Number Title Priority Date Filing Date
NO860191A NO166302C (no) 1985-01-22 1986-01-21 Fremgangsmaate for diagnose av reumatoid artritt eller osteoartritt.

Country Status (14)

Country Link
US (1) US4659659A (fi)
EP (1) EP0189388B1 (fi)
JP (1) JP2515289B2 (fi)
AT (1) ATE78518T1 (fi)
AU (1) AU586662B2 (fi)
CA (1) CA1272670A (fi)
DE (1) DE3686061T2 (fi)
DK (1) DK164417C (fi)
FI (1) FI88341C (fi)
GR (1) GR860167B (fi)
IE (1) IE58727B1 (fi)
IL (1) IL77666A (fi)
NO (1) NO166302C (fi)
ZA (1) ZA86442B (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659659A (en) * 1985-01-22 1987-04-21 Monsanto Company Diagnostic method for diseases having an arthritic component
GB8618443D0 (en) * 1986-07-29 1986-09-03 Univ London Monoclonal antibodies
GB8714270D0 (en) * 1987-06-18 1987-07-22 Williams G R Analysis of carbohydrates
US4791067A (en) * 1987-06-25 1988-12-13 Fisher Scientific Co. Agglutination immunoassay for hapten involving monoclonal antibody of IgA class reagent
CA2016125A1 (en) * 1989-05-19 1990-11-19 Eisai Co., Ltd. Diagnostic drug for rheumatoid arthritis
US5089409A (en) * 1989-09-28 1992-02-18 Monsanto Company Method of increasing specific activity of t-pa
US5100778A (en) * 1989-10-03 1992-03-31 Monsanto Company Oligosaccharide sequencing
US5164374A (en) * 1990-12-17 1992-11-17 Monsanto Company Use of oligosaccharides for treatment of arthritis
JP3537535B2 (ja) * 1994-07-14 2004-06-14 株式会社中埜酢店 免疫グロブリンg結合糖鎖構造に基づく臨床検査方法
US6159748A (en) * 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
US5846758A (en) * 1995-11-30 1998-12-08 His Excellency Ghassan I. Shaker Method for diagnosing autoimmune diseases
IL129835A (en) * 1999-05-06 2008-03-20 Ofer Markman Polysaccharide sequencing and structure determination
US7407773B2 (en) * 2000-11-03 2008-08-05 Procognia, Ltd. Method for characterizing a carbohydrate polymer
US20040132131A1 (en) * 2001-11-05 2004-07-08 Ofer Markman Methods for comparitive analysis of carbohydrate polymers and carbohydrate polymers identified using same
EP1583968B1 (en) * 2003-01-14 2015-04-22 VIB, vzw A serum marker for measuring liver fibrosis
WO2004082617A2 (en) * 2003-03-14 2004-09-30 Ppd Biomarker Discovery Sciences, Llc Biological markers for diagnosing rheumatoid arthritis
WO2005015200A1 (ja) * 2003-08-11 2005-02-17 Shionogi Co., Ltd. 血清を用いた簡易疾患診断およびテーラーメイド治療
US20050186645A1 (en) * 2003-12-18 2005-08-25 Yehudit Amor Method for analyzing a glycomolecule
WO2006007664A1 (en) * 2004-07-22 2006-01-26 Genomics Research Partners Pty Ltd Agents and methods for diagnosing osteoarthritis
US7892752B2 (en) * 2005-04-26 2011-02-22 Dwek Raymond A Glycosylation markers for cancer diagnosing and monitoring
US20060269979A1 (en) * 2005-04-26 2006-11-30 Dwek Raymond A High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases
US8039208B2 (en) * 2005-04-26 2011-10-18 National Institute For Bioprocessing Research And Training Limited (Nibrt) Automated strategy for identifying physiological glycosylation markers(s)
NZ569979A (en) * 2005-06-10 2011-08-26 Mannatech Inc Rapid saccharide biomarker assay
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
CA2662921C (en) 2006-09-26 2018-11-20 Infectious Disease Research Institute Vaccine and pharmaceutical compositions and kits and uses thereof in stimulating an immune response with a synthetic glucopyranosyl lipid adjuvant
WO2009078015A2 (en) * 2007-12-18 2009-06-25 Procognia (Israel) Ltd Method and assay for glycosylation pattern detection related to cell state of stem cells
WO2010141861A1 (en) * 2009-06-05 2010-12-09 Infectious Disease Research Institute Synthetic glucopyranosyl lipid adjuvants
SG194083A1 (en) 2011-04-08 2013-11-29 Immune Design Corp Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
ES2729967T3 (es) 2012-02-07 2019-11-07 Infectious Disease Res Inst Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
WO2013173590A1 (en) 2012-05-16 2013-11-21 Immune Design Corp. Vaccines for hsv-2
EA032326B1 (ru) 2013-04-18 2019-05-31 Иммьюн Дизайн Корп. Монотерапия gla для применения в лечении рака
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
CN106163551A (zh) 2013-12-31 2016-11-23 传染性疾病研究院 单瓶疫苗制剂
AU2017273650B2 (en) 2016-06-01 2022-08-18 Access To Advanced Health Institute Nanoalum particles containing a sizing agent
MX2021014363A (es) 2019-05-25 2022-02-21 Infectious Disease Res Inst Composicion y metodo para secar por pulverizacion una emulsion de vacuna adyuvante.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3088875A (en) * 1959-10-27 1963-05-07 Hyland Lab Immunological diagnostics utilizing polystyrene latex particles of 0.15 to 0.25 micron
US4189466A (en) * 1975-09-19 1980-02-19 Technical Research Affiliates, Inc. Detection of rheumatoid factor by antibody sensitized microbial particles
US4213764A (en) * 1978-08-09 1980-07-22 Akzona Incorporated Method for determining immunochemical substances
US4282002A (en) * 1979-09-06 1981-08-04 Akzona Incorporated Sensitized sheep stroma immunoassay for rheumatoid factor
SE447028B (sv) * 1980-06-30 1986-10-20 Erik Audunn Cerven Bestemning av endstaende sackaridgrupper i glykoprotein
US4457865A (en) * 1982-03-08 1984-07-03 Research Corporation Sialic acid specific slug lectin
US4420461A (en) * 1982-05-26 1983-12-13 Ortho Diagnostic Systems Inc. Agglutination-inhibition test kit for detecting immune complexes
US4659659A (en) * 1985-01-22 1987-04-21 Monsanto Company Diagnostic method for diseases having an arthritic component

Also Published As

Publication number Publication date
NO166302B (no) 1991-03-18
FI88341C (fi) 1993-04-26
DK164417C (da) 1992-11-16
ZA86442B (en) 1986-10-29
DK29086D0 (da) 1986-01-21
EP0189388A3 (en) 1988-11-30
DE3686061D1 (de) 1992-08-27
IE860176L (en) 1986-07-22
AU5253886A (en) 1986-07-31
DK164417B (da) 1992-06-22
FI88341B (fi) 1993-01-15
EP0189388A2 (en) 1986-07-30
JP2515289B2 (ja) 1996-07-10
JPS61170657A (ja) 1986-08-01
ATE78518T1 (de) 1992-08-15
CA1272670C (en) 1990-08-14
EP0189388B1 (en) 1992-07-22
FI860284A (fi) 1986-07-23
AU586662B2 (en) 1989-07-20
GR860167B (en) 1986-05-22
CA1272670A (en) 1990-08-14
NO860191L (no) 1986-07-23
DE3686061T2 (de) 1993-03-11
IL77666A (en) 1990-12-23
IE58727B1 (en) 1993-11-03
US4659659A (en) 1987-04-21
DK29086A (da) 1986-07-23
FI860284A0 (fi) 1986-01-21

Similar Documents

Publication Publication Date Title
NO166302C (no) Fremgangsmaate for diagnose av reumatoid artritt eller osteoartritt.
ES2014540A6 (es) Metodo para la determinacion de fragmentos peptidicos con un entrecruzamiento 3-hidroxipiridinio en un fluido corporal.
AU4499685A (en) In vitro detection of gastrointestinal cancer
DE3587724D1 (de) Antikörper verwendende diagnostische Methoden.
AU3575089A (en) Method of detecting bacteria in urine
WO1995005604A3 (en) Methods for the diagnosis of alzheimer's disease
ATE347697T1 (de) Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten
EP0329682A4 (en) A method for ascertaining the history of a condition of the body from a single blood sample
AU2353188A (en) A diagnostic agent and a method for the determination of apolipoprotein b
FI922666A0 (fi) Diagnostiskt foerfarande.
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
EP0217768A3 (en) Method and compositions for heparin assays
NO902158D0 (no) Proteinholdig forbindelse for diagnostisk anvendelse.
GR900100011A (en) New diagnostic method
EP0170200A3 (en) Breast cyst fluid screening method for cancer risk assessment
EP0788595A4 (en) METHOD FOR TESTING IMMUNOCOMPETENCY
SG45274A1 (en) Method and apparatus for measuring the degree of reaction between a foreign entity and a subject's blood cells
ES8500457A1 (es) Un metodo para determinar la capacidad oxidante de un liquido biologico.
Fusaro et al. Hypergammaglobulinemia, Secondary Macroglobulinemia and Paraproteinemia in'Leprosy
AU7692987A (en) Reagent kit, its use and diagnostic process for the detection of hpasp(human pancreatic specific protein)
UA10243A (uk) Спосіб диференційної діагностики вірусних гепатитів а і в у дітей
UA28862A (uk) Спосіб визначення необхідності тестування на вілінфекцію
NO921879L (no) Fremgangsmaate til maaling av t-celleoverflateantigener i mennesker